Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (711-720 of 727) with videos related to

Pageof 73
Sort By:
Alimentary Pharmacology & Therapeutics|December 3, 2016
An expert consensus definition of failure of a treatment to provide adequate relief (F-PAR) for chronic constipation - an international Delphi surveyJ Tack, H Boardman, P Layer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 14, 2021
The challenge of choosing in cardiovascular risk managementR M Hoogeveen, N M J Hanssen, J R Brouwer, et al.
Nature Communications|January 13, 2015
Corrigendum: IL-37 protects against obesity-induced inflammation and insulin resistanceDov B Ballak, Janna A van Diepen, Alexander R Moschen, et al.
Nature Communications|September 4, 2014
IL-37 protects against obesity-induced inflammation and insulin resistanceDov B Ballak, Janna A van Diepen, Alexander R Moschen, et al.
BMJ Open Diabetes Research & Care|February 29, 2020
High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl CohortLian A van Meijel, Femmie de Vegt, Evertine J Abbink, et al.
BMJ Open Diabetes Research & Care|October 7, 2020
Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohortMarit de Jong, Marieke J Oskam, Simone J S Sep, et al.
Diabetologia|November 15, 2018
Increased NEFA levels reduce blood Mg<sup>2+</sup> in hypertriacylglycerolaemic states via direct binding of NEFA to Mg<sup>2</sup>Steef Kurstjens, Jeroen H F de Baaij, Caro Overmars-Bos, et al.
Nature Medicine|May 30, 2006
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistanceMihai G Netea, Leo A B Joosten, Eli Lewis, et al.
Cell Metabolism|November 27, 2010
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivityRinke Stienstra, Leo A B Joosten, Tim Koenen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 14, 2017
Individual and partner's level of occupation and the association with HbA<sub>1c</sub> levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohortA Rutte, S P Rauh, M T Schram, et al.
Pageof 73

Showing results (711-720 of 727) with videos related to

Sort By:
Pageof 73
Alimentary Pharmacology & Therapeutics|December 3, 2016
An expert consensus definition of failure of a treatment to provide adequate relief (F-PAR) for chronic constipation - an international Delphi surveyJ Tack, H Boardman, P Layer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 14, 2021
The challenge of choosing in cardiovascular risk managementR M Hoogeveen, N M J Hanssen, J R Brouwer, et al.
Nature Communications|January 13, 2015
Corrigendum: IL-37 protects against obesity-induced inflammation and insulin resistanceDov B Ballak, Janna A van Diepen, Alexander R Moschen, et al.
Nature Communications|September 4, 2014
IL-37 protects against obesity-induced inflammation and insulin resistanceDov B Ballak, Janna A van Diepen, Alexander R Moschen, et al.
BMJ Open Diabetes Research & Care|February 29, 2020
High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl CohortLian A van Meijel, Femmie de Vegt, Evertine J Abbink, et al.
BMJ Open Diabetes Research & Care|October 7, 2020
Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohortMarit de Jong, Marieke J Oskam, Simone J S Sep, et al.
Diabetologia|November 15, 2018
Increased NEFA levels reduce blood Mg<sup>2+</sup> in hypertriacylglycerolaemic states via direct binding of NEFA to Mg<sup>2</sup>Steef Kurstjens, Jeroen H F de Baaij, Caro Overmars-Bos, et al.
Nature Medicine|May 30, 2006
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistanceMihai G Netea, Leo A B Joosten, Eli Lewis, et al.
Cell Metabolism|November 27, 2010
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivityRinke Stienstra, Leo A B Joosten, Tim Koenen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 14, 2017
Individual and partner's level of occupation and the association with HbA<sub>1c</sub> levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohortA Rutte, S P Rauh, M T Schram, et al.
Pageof 73